# Trade Mark Journal No.2025/042 17 October 2025

## WO0000001879467 (42)

Office of origin: Australia

Date of International Registration:28 August 2025
Date of designation in the UK: 28 August 2025

Class 42
  Clinical trials; clinical research; clinical research services; testing of pharmaceuticals; all of the foregoing in relation to nuclear medicine.

Telix Pharmaceuticals Limited

Representative: Herbert Smith Freehills Kramer, Level 24,, 80 Collins Street, MELBOURNE VIC 3000, AUSTRALIA